A new enzyme immunoassay specific for blastomycosis

The American Review of Respiratory Disease
C Y Lo, R H Notenboom

Abstract

A highly specific enzyme immunoassay (EIA) was developed for the serodiagnosis of blastomycosis. Among the earliest sera available from eight active cases of blastomycosis, seven were reactive by EIA, three by immunodiffusion, and three by complement fixation. The one seronegative case was associated with acquired immunodeficiency syndrome (AIDS). No cross-reaction was observed with sera from 12 patients with active histoplasmosis or from five patients with active coccidioidomycosis or from 23 healthy persons. In contrast, all patients' sera cross-reacted in conventional EIAs based on commercial immunodiffusion antigens. The blastomycosis-specific EIA seems to offer sensitivity without compromising specificity. Rheumatoid factors, which could cause false-positive reactions, were controlled for.

Citations

Apr 21, 2009·Clinics in Chest Medicine·James A McKinnell, Peter G Pappas
Mar 29, 2000·The Annals of Otology, Rhinology, and Laryngology·J M HansonS K El-Mofty

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Related Papers

International Journal of Dermatology
L E Millikan, J P Shrum
Journal of Neurology, Neurosurgery, and Psychiatry
C KrarupR J Hay
Surgical Neurology
E C BenzelT A Hadden
Clinical Techniques in Small Animal Practice
N Ehrhart
© 2021 Meta ULC. All rights reserved